Loading clinical trials...
Loading clinical trials...
A Real Life, Non-interventional, Multicentre Study to Assess Resource Utilization and Quality of Life of Patients With Relapsing Forms of Multiple Sclerosis Treated With Dimethyl Fumarate in Greece - the FIDELITY Study
Conditions
Interventions
Dimethyl Fumarate (DMF)
Locations
1
Greece
University General Hospital AHEPA (B')
Thessaloniki, Greece
Start Date
September 23, 2016
Primary Completion Date
April 23, 2020
Completion Date
April 23, 2020
Last Updated
July 28, 2021
NCT05304520
NCT02881567
NCT02035514
NCT02568111
NCT00787657
NCT01499667
Lead Sponsor
Genesis Pharma CNS & Specialty
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions